IP Review

This fragment is available on copyright.html

This publication includes IP covered under the following statements.

ISO Maintains the copyright on the country codes, and controls it's use carefully. For futher details see the ISO 3166 web page: https://www.iso.org/iso-3166-country-codes.html
Show Usage
- ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code : EHDSICountry
Produced by HL7 under the terms of HL7® Governance and Operations Manual relating to Intellectual Property (Section 16), specifically its copyright, trademark and patent provisions. This document is licensed under Creative Commons "No Rights Reserved" (CC0).
Show Usage
- Absent and Unknown Data - IPS : EHDSIAbsentOrUnknownAllergy , EHDSIAbsentOrUnknownDevice , EHDSIAbsentOrUnknownMedication , EHDSIAbsentOrUnknownProblem and EHDSIAbsentOrUnknownProcedure
The UCUM codes, UCUM table (regardless of format), and UCUM Specification are copyright 1999-2009, Regenstrief Institute, Inc. and the Unified Codes for Units of Measures (UCUM) Organization. All rights reserved. https://ucum.org/trac/wiki/TermsOfUse
Show Usage
- Unified Code for Units of Measure (UCUM) : EHDSIUnit
These codes are excerpted from Digital Imaging and Communications in Medicine (DICOM) Standard, Part 16: Content Mapping Resource, Copyright Â© 2011 by the National Electrical Manufacturers Association.
Show Usage
- DICOM Controlled Terminology Definitions: EHDSIModality and EHDSITechnicalModality
This artifact includes content from International Standard Classification of Occupations (ISCO). ISCO is copyright International Labour Organization (ILO). Terms & Conditions in http://www.ilo.org/global/copyright/lang--en/index.htm
Show Usage
- International Standard Classification of Occupations (ISCO) : EHDSIHealthcareProfessionalRole
This material contains content from LOINC . LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license . LOINC® is a registered United States trademark of Regenstrief Institute, Inc.
Show Usage
- LOINC : EHDSIBloodPressure , EHDSIDocumentCode ... Show 10 more
This material contains content that is copyright of SNOMED International. Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact https://www.snomed.org/get-snomed or info@snomed.org .
Show Usage
- SNOMED Clinical Terms® (SNOMED CT®) : EHDSIAdverseEventType , EHDSIAllergenNoDrug ... Show 34 more
This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html
Show Usage
Unless otherwise indicated, reproduction of material posted on Council of Europe websites, and reproduction of photographs for which the Council of Europe holds copyright – see legal notice \“photo credits\” – is authorised for private use and for informational and educational uses relating to the Council of Europe’s work. This authorisation is subject to the condition that the source be indicated and no charge made for reproduction. Persons wishing to make some other use than those specified above, including commercial use, of information and text posted on these sites are asked to apply for prior written authorisation to the Council of Europe, Directorate of Communication.
Show Usage
- EDQM Standard Terms : EHDSIDoseForm , EHDSIPackage , EHDSIQuantityUnit and EHDSIRouteofAdministration

hl7.fhir.us.hai: Healthcare Associated Infection Implementation Guide ®© HL7 | CC0 ( src )

((1R,3S)-1-amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol ( src )

((R)-7-((1-(6-cyanopyridazin-3-yl)-3,3-dimethylpiperidin-4-yl)amino)-2-(6-methoxypyridin-2-yl)pyrazolo [1,5-a]pyrimidine-6-carboxamide) ( src )

((Trans)-4-((2-(((2-chloro-4-((((R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)carbamoyl)oxy)ethyl)(methyl)amino)cyclohexyl 2-hydroxy-2,2-di(thiophen-2-yl)acetate ( src )

(-)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluorobutyl-1-sulfonate ( src )

(R)-(-)-N-(2-(3-((6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)carbonyl)piperidino)ethyl)-4-fluorobenzamide ( src )

(R)-(3-(2'-cyclopropyl-3-(hydroxymethyl)-[1,1'-biphenyl]-4-yl) pyrrolidin-1-yl)(5-fluoropyridin-2-yl)methanone ( src )

(R)-(3-(2'-cyclopropyl-3-(hydroxymethyl)-[1,1'-biphenyl]-4-yl)pyrrolidin-1-yl)(5-hydroxy-6-methylpyridin-2-yl)methanone ( src )

(R)-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrile ( src )

(R)-1-(1-Acryloylpiperidin-3-yl)-4-amino-N-(4-(2-(dimethylamino)-2-oxoethyl)-2,3-dimethylphenyl)-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamide ( src )

(R)-1-(5-tert-butyl-indan-1-yl)-3-(1H-indazol-4-yl)-urea ( src )

(R)-1-(tert-butyl)-N-(8-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-2-(oxetan-3-yl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-5-yl)-1H-1,2,3-triazole-4-carboxamide ( src )

(R)-2-(4-(Cyclopropylsulfonyl)phenyl)-N-(pyrazin-2-yl)-3-(tetrahydro-2H-pyran-4-yl)propanamide ( src )

(R)-2-(5-cyano-2-(6-(methoxycarbonyl)-7-methyl-3-oxo-8-(3-(trifluoromethyl)phenyl)-2,3,5,8-tetrahydro-(1,2,4)triazolo(4,3-a)pyrimidin-5-yl)phenyl)-n,n,n-trimethylethanaminium methanesulfonate ( src )

(R)-2-Amino-7-(4-fluoro-2-(6-methoxypyridin-2-yl)phenyl)-4-[11C]methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5(6H)-one ( src )

(R)-2-Amino-7-(4-fluoro-2-(6-methoxypyridin-2-yl)phenyl)-4-methyl-7,8-dihydro-6H-pyrido(4,3-d)pyrimidin-5-one ( src )

(R)-3,3,3-trifluoro-N-(2-fluoro-5-trifluoromethylbenzyl)-2-hydroxy-2-phenylpropanamide ( src )

(R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea ( src )

(R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea fumarate ( src )

(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione ( src )

(R)-3-(5-Dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1methylethyl)benzamide ( src )

(R)-3-Chloro-1,2-propanediol ( src )

(R)-4-((3-(1H-Imidazol-1-yl)-6,6-dimethylcyclohex-2-en-1-yl)(methyl)amino)-2-(trifluoromethyl)benzonitrile ( src )

(R)-4-((5-(3-hydroxy-3-methyl-2-oxoindolin-1-yl)pyridin-3-yl)methyl)phthalazin-1(2H)-one ( src )

(R)-4-((5-(3-hydroxy-3-methyl-2-oxoindolin-1-yl)pyridin-3-yl)methyl)phthalazin-1(2H)-one mesilate ( src )

(R)-5-((4-((Morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile ( src )

(R)-6-((3,3-Difluoro-1-methylpiperidin-4-yl)oxy)-N-(3-ethynyl-2-fluorophenyl)-7-methoxyquinazolin-4-amine ( src )

(R)-6-((3,3-Difluoro-1-methylpiperidin-4-yl)oxy)-N-(3-ethynyl-2-fluorophenyl)-7-methoxyquinazolin-4-amine-fumarate (2:1) ( src )

(R)-6-(4-((4-ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine ( src )

(R)-ALPHA-GLYCEROPHOSPHORYLETHANOLAMINE MONOHYDRATE ( src )

(R)-Bicalutamide ( src )

(R)-Deuteropioglitazone ( src )

(R)-Deuteropioglitazone hydrochloride ( src )

(R)-Glycidyl tosilate ( src )

(R)-Ketamine ( src )

(R)-Ketamine hydrochloride ( src )

(R)-Mequitazine ( src )

(R)-N-(1-(3-(Cyclopentyloxy)phenyl)ethyl)-3-((2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy)propane-1-sulfonamide ( src )

(R)-N-(1-carboxy-3-((phenylacetyl)amino)propyl)-L-leucyl-N,O-dimethyl-L-tyrosinamide ( src )

(R)-N-(3-(2-Chloro-5-fluorophenyl)-6-(5-cyano-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1-oxoisoindolin-4-yl)-3-fluoro-5-(trifluoromethyl)benzamide ( src )

(R)-N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)cyclopropanecarboxamide ( src )

(R)-N-(4-([1,2,4]-Triazolo[1,5-c]-pyrimidin-7-yloxy)-3-methylphenyl)-5-((3,3-difluoro-1-methylpiperidin-4-yl)oxy)-6-methoxyquinazolin-4-amine ( src )

(R)-N-(4-([1,2,4]-Triazolo[1,5-c]-pyrimidin-7-yloxy)-3-methylphenyl)-5-((3,3-difluoro-1-methylpiperidin-4-yl)oxy)-6-methoxyquinazolin-4-amine fumarate ( src )

(R)-Otenaproxesul ( src )

(R)-Styrene oxide ( src )

(R)-Warfarin ( src )

(R)-alpha-glycerophosphorylethanolamine ( src )

(R)-fadrozole phosphate ( src )

(R)-troloxamide quinone ( src )

(S)-4-(((R)-6-(2-Chloro-4-fluorophenyl)-5-(methoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholine-3-carboxylic acid ( src )

(S)-Quinuclidin-3-yl((R)-5-(3-chloro-4-isopropoxyphenyl)-2,2-dimethyl-2,3-dihydro-1H-inden-1-yl)carbamate ( src )

(S)-Quinuclidin-3-yl((R)-5-(3-chloro-4-isopropoxyphenyl)-2,2-dimethyl-2,3-dihydro-1H-inden-1-yl)carbamate ((1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate ( src )

(r)-4-((4-(((4-(tetrahydrofuran-3-yloxy)-1,2-benzisoxazol-3-yl)oxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol ( src )

1-(4'-(3-methyl-4-(((((R)-1-phenylethyl)oxy)carbonyl)amino)isoxazol-5-yl)biphenyl-4-yl)cyclopropanecarboxylic acid ( src )

2-((R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl)-N-((R)-2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide ( src )

2-[[Hydroxy[(R)-2-[((5Z,8Z,11Z,14Z)-eicosa-5,8,11,14-tetraenoyl)oxy]-3-(octadecyloxy)propoxy]phosphoryl]oxy]ethan-1-amine ( src )

3-((4-(1-((1-(6-(((S)-2,6-Dioxopiperidin-3-yl)carbamoyl)pyridin-3-yl)piperidin-4-yl)methyl)piperidin-4-yl)phenyl)amino)-5-((R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide ( src )

3-((S)-4-(5-((4-(4-chlorothiophen-2-yl)-5-(((R)-2-methylpyrrolidin-1-yl)methyl)thiazol-2-yl)carbamoyl)pyrazin-2-yl)-2-methylpiperazin-1-yl)propanoic acid ( src )

4-[(5-bromo-4-{[(R)-1-hydroxypropan-2-yl]amino}pyrimidin-2-yl)amino]benzenesulfonamide ( src )

4-[4-[(R)-[2-(4-Chlorophenyl)phenyl]-hydroxymethyl]piperidin-1-yl]-N-[4-[[(2R)-4-[2-hydroxyethyl(methyl)amino]-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide ( src )

4-{(R)-(3-aminophenyl)[4-(4-fluorobenzyl)-piperazin-1-yl]methyl}-N,N-diethylbenzamide ( src )

4-{(R)-(3-aminophenyl)[4-(4-fluorobenzyl)-piperazin-1-yl]methyl}-N,N-diethylbenzamide sesquifumarate ( src )

9(R)-Hexahydrocannabiphorol ( src )

9-[2-(R)-(Phosphonomethoxy)propyl]-2,6-diaminopurine ( src )

ADENOSINE, (P(R))-5'-O-((R)-HYDROXYMERCAPTOPHOSPHINYL)-P-THIOADENYLYL-(2'->5')-, CYCLIC NUCLEOTIDE ( src )

ADENOSINE, (P(R))-5'-O-((R)-HYDROXYMERCAPTOPHOSPHINYL)-P-THIOADENYLYL-(2'->5')-, CYCLIC NUCLEOTIDE, SODIUM SALT (1:2) ( src )

AMPHISOL® K ( src )

Bg sup(c) Ag [Presence] on Red Blood Cells ( src )

Copyright/Legal: The Value Set incorporates SNOMED CT®, used by permission of the International Health Terminology Standards Development Organisation, trading as SNOMED International. SNOMED CT was originally created by the College of American Pathologists. SNOMED CT is a registered trademark of the International Health Terminology Standards Development Organisation, all rights reserved. For further information on the use of SNOMED CT, including translations, implementers of MyHealth@EU should review usage terms or directly contact SNOMED International: info@snomed.org. ( src )

Copyright/Legal: This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc ( src )

McC sup(c) Ab [Presence] in Serum or Plasma ( src )

Methyl (R)-3-chloro-3'-fluoro-4'-(1-(1-(2,2,2-trifluoroacetamido)cyclopropane-1-carboxamido)ethyl)-[1,1'-biphenyl]-2-carboxylate ( src )

Methyl(R)-4-((3S,5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-((4-((pyridin-2-ylmethyl)amino)butyl)amino)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate ( src )

Methyl(R)-4-((3S,5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-((4-((pyridin-3-ylmethyl)amino)butyl)amino)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate ( src )

N-((S)-1,1-Dicyclopropyl-3-((4-((2S,3R)-4-((R)-3,4-dimethylpiperazin-1-yl)-3-((S)-2-methoxypropanamido)-4-oxobutan-2-yl)-2-fluorophenyl)amino)-3-oxopropan-2-yl)-1-ethyl-1H-pyrazole-5-carboxamide ( src )

N-(2-hydroxyethyl)-2-((Z)-4,4,7-trifluoro-1-(4-((R)-2-fluoropropoxy)-2-(trifluoromethyl)benzoyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-5-ylidene)acetamide ( src )

Produced by HL7 under the terms of HL7® Governance and Operations Manual relating to Intellectual Property (Section 16), specifically its copyright, trademark and patent provisions. This document is licensed under Creative Commons "No Rights Reserved" (CC0). Show Usage * Absent and Unknown Data - IPS: EHDSIAbsentOrUnknownAllergy, EHDSIAbsentOrUnknownDevice, EHDSIAbsentOrUnknownMedication, EHDSIAbsentOrUnknownProblem and EHDSIAbsentOrUnknownProcedure ( src )

Sodium (R)-2-(2-amino-3-(1H-indol-3- yl)propanamido)-2-methylpropanoate-propan-2-ol ( src )

TEKPRINT ® SB 1010 N RED2 ( src )

These codes are excerpted from Digital Imaging and Communications in Medicine (DICOM) Standard, Part 16: Content Mapping Resource, Copyright Â© 2011 by the National Electrical Manufacturers Association. Show Usage * DICOM Controlled Terminology Definitions: EHDSIModality and EHDSITechnicalModality ( src )

This material contains content from LOINC. LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc. Show Usage * LOINC: EHDSIBloodPressure, EHDSIDocumentCode... Show 10 more, EHDSIHospitalDischargeReportType, EHDSIImagingCode, EHDSILabCode, EHDSILabStudyType, EHDSILaboratoryReportType, EHDSIMedicalImagesType, EHDSIMedicalImagingReportType, EHDSIPregnancyInformation, EHDSISection and EHDSIVitalSignCode ( src )

This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html Show Usage * AllergyIntolerance Clinical Status Codes: EHDSIAllergyStatus * AllergyIntolerance Verification Status: EHDSIAllergyCertainty * ConditionVerificationStatus: EHDSICertainty * DataAbsentReason: EHDSIDataAbsentReason * Discharge disposition: EHDSIDischargeDisposition * Observation Category Codes: EHDSIObservationCategory * Observation Reference Range Meaning Codes: EHDSIReferenceRangeMeaning * Sex Parameter For Clinical Use: EHDSIReferenceRangeAppliesTo * ActCode: EHDSIEncounterClass * ActPriority: EHDSIAdmissionUrgency * AddressUse: EHDSITelecomAddress * AdministrativeGender: EHDSIAdministrativeGender * NullFlavor: EHDSIExceptionalValue and EHDSINullFlavor * ObservationInterpretation: EHDSIObservationInterpretation * ParticipationType: EHDSIPerformerFunction * RoleClass: EHDSIRoleClass * RoleCode: EHDSIClinLocRoleType and EHDSIPersonalRelationship * TimingEvent: EHDSITimingEvent * Media Type: EHDSIMediaType * Substance Admin Substitution: EHDSISubstitutionCode ( src )

External References

Unattributed Code Systems

Copyright Fragment

Copyright and Registered Trademark Uses

External References

Internal Images